C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.38 CNY -0.12% Market Closed
Market Cap: 25.9B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China National Medicines Corp Ltd
Gross Profit Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Gross Profit
ÂĄ3.8B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
16%
Sinopharm Group Co Ltd
HKEX:1099
Gross Profit
ÂĄ47.2B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
12%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Gross Profit
ÂĄ29.7B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Gross Profit
ÂĄ11.1B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
16%
Huadong Medicine Co Ltd
SZSE:000963
Gross Profit
ÂĄ13.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
13%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Gross Profit
ÂĄ2.3B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Gross Profit?
Gross Profit
3.8B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Gross Profit amounts to 3.8B CNY.

What is China National Medicines Corp Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
16%

Over the last year, the Gross Profit growth was -3%. The average annual Gross Profit growth rates for China National Medicines Corp Ltd have been 4% over the past three years , 2% over the past five years , and 16% over the past ten years .

Back to Top